These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 21786198)

  • 1. Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.
    Chakroborty S; Stutzmann GE
    Sci China Life Sci; 2011 Aug; 54(8):752-62. PubMed ID: 21786198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"?
    Stutzmann GE
    Neuroscientist; 2007 Oct; 13(5):546-59. PubMed ID: 17901262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity.
    Vincent AJ; Gasperini R; Foa L; Small DH
    J Alzheimers Dis; 2010; 22(3):699-714. PubMed ID: 20847426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis.
    Supnet C; Bezprozvanny I
    Sci China Life Sci; 2011 Aug; 54(8):744-51. PubMed ID: 21786197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.
    Yu JT; Chang RC; Tan L
    Prog Neurobiol; 2009 Nov; 89(3):240-55. PubMed ID: 19664678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of synaptic dysfunction in Alzheimer's disease.
    Masliah E
    Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.
    Proctor DT; Coulson EJ; Dodd PR
    Prog Neurobiol; 2011 Apr; 93(4):509-21. PubMed ID: 21382433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Abeta-induced calcium dysregulation in the pathogenesis of Alzheimer's disease.
    Small DH; Gasperini R; Vincent AJ; Hung AC; Foa L
    J Alzheimers Dis; 2009; 16(2):225-33. PubMed ID: 19221414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
    LaFerla FM; Oddo S
    Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.
    Smith IF; Green KN; LaFerla FM
    Cell Calcium; 2005; 38(3-4):427-37. PubMed ID: 16125228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
    Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
    Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?
    Marchetti C; Marie H
    Rev Neurosci; 2011; 22(4):373-402. PubMed ID: 21732714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.